ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 123 filers reported holding ROYALTY PHARMA PLC in Q2 2020. The put-call ratio across all filers is 0.58 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,406,835 | -11.4% | 530,834 | +0.4% | 0.01% | -13.3% |
| Q2 2023 | $16,260,015 | -15.8% | 528,953 | -1.3% | 0.02% | -16.7% |
| Q1 2023 | $19,310,891 | -10.1% | 535,967 | -1.4% | 0.02% | -14.3% |
| Q4 2022 | $21,477,579 | -0.9% | 543,461 | +0.8% | 0.02% | -8.7% |
| Q3 2022 | $21,663,000 | -4.4% | 539,143 | +0.0% | 0.02% | 0.0% |
| Q2 2022 | $22,661,000 | +51.1% | 539,034 | +40.1% | 0.02% | +76.9% |
| Q1 2022 | $14,994,000 | +2985.2% | 384,844 | +3748.4% | 0.01% | +1200.0% |
| Q2 2020 | $486,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |